{"title": "Study questions value of genetic risk scores", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/heart_disease.xml", "value": "Study questions value of genetic risk scores"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190325112246.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190325112246.htm", "summary": "What's known as the genome-wide polygenic score, or GPS, combines information from many thousands of genetic markers, each with only a minimal effect, to produce an overall assessment of disease risk based on an individual's entire genetic background. While a recent publication claimed that the GPS could be used by doctors to identify patients at high risk of conditions such as heart disease, cancer, and diabetes, a new study casts doubt on these claims.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/heart_disease.xml", "value": "What's known as the genome-wide polygenic score, or GPS, combines information from many thousands of genetic markers, each with only a minimal effect, to produce an overall assessment of disease risk based on an individual's entire genetic background. While a recent publication claimed that the GPS could be used by doctors to identify patients at high risk of conditions such as heart disease, cancer, and diabetes, a new study casts doubt on these claims."}, "published": "Mon, 25 Mar 2019 11:22:46 EDT", "published_parsed": [2019, 3, 25, 15, 22, 46, 0, 84, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190325112246.htm", "guidislink": false}